Complexity of Dopamine Metabolism

Overview

Journal Cell Commun Signal

Publisher Biomed Central

Specialties Biochemistry
Cell Biology

Date 2013 May 21

PMID 23683503

Citations 255

Authors

Johannes Meiser

Daniel Weindl

Karsten Hiller

Affiliations

Soon will be listed here.

Abstract

: Parkinson's disease (PD) coincides with a dramatic loss of dopaminergic neurons within the substantia nigra. A key player in the loss of dopaminergic neurons is oxidative stress. Dopamine (DA) metabolism itself is strongly linked to oxidative stress as its degradation generates reactive oxygen species (ROS) and DA oxidation can lead to endogenous neurotoxins whereas some DA derivatives show antioxidative effects. Therefore, DA metabolism is of special importance for neuronal redox-homeostasis and viability.In this review we highlight different aspects of dopamine metabolism in the context of PD and neurodegeneration. Since most reviews focus only on single aspects of the DA system, we will give a broader overview by looking at DA biosynthesis, sequestration, degradation and oxidation chemistry at the metabolic level, as well as at the transcriptional, translational and posttranslational regulation of all enzymes involved. This is followed by a short overview of cellular models currently used in PD research. Finally, we will address the topic from a medical point of view which directly aims to encounter PD.

Citing Articles

Aging disrupts the coordination between mRNA and protein expression in mouse and human midbrain.

Buck S, Mabry S, Glausier J, Banks-Tibbs T, Ward C, Kozel J Mol Psychiatry. 2025; .

PMID: 39875589 DOI: 10.1038/s41380-025-02909-1.

Doxorubicin treatment has a biphasic effect over time on dopamine release and impulsive behavior in Wistar rats.

Garcia K, Theismann J, Schneider T, LeComte R, Jarmolowicz D, Johnson M Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39820646 DOI: 10.1007/s00210-024-03766-5.

Growing meat on autoclaved vegetables with biomimetic stiffness and micro-patterns.

Liu Y, Gao A, Wang T, Zhang Y, Zhu G, Ling S Nat Commun. 2025; 16(1):161.

PMID: 39746945 PMC: 11695936. DOI: 10.1038/s41467-024-55048-6.

Biochemical Sensors for Personalized Therapy in Parkinson's Disease: Where We Stand.

Ciarrocchi D, Pecoraro P, Zompanti A, Pennazza G, Santonico M, di Biase L J Clin Med. 2024; 13(23).

PMID: 39685917 PMC: 11641839. DOI: 10.3390/jcm13237458.

Lethal and Sublethal Toxicity of Nanosilver and Carbon Nanotube Composites to -A Toxicogenomic Approach.

Auclair J, Roubeau-Dumont E, Gagne F Nanomaterials (Basel). 2024; 14(23).

PMID: 39683342 PMC: 11643480. DOI: 10.3390/nano14231955.

References

Hadjiconstantinou M, Wemlinger T, Sylvia C, Hubble J, Neff N . Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors. J Neurochem. 1993; 60(6):2175-80. DOI: 10.1111/j.1471-4159.1993.tb03503.x. View

Bracher A, Eisenreich W, Schramek N, Ritz H, GOTZE E, Herrmann A . Biosynthesis of pteridines. NMR studies on the reaction mechanisms of GTP cyclohydrolase I, pyruvoyltetrahydropterin synthase, and sepiapterin reductase. J Biol Chem. 1998; 273(43):28132-41. DOI: 10.1074/jbc.273.43.28132. View

Nakashima A, Hayashi N, Kaneko Y, Mori K, Sabban E, Nagatsu T . RNAi of 14-3-3eta protein increases intracellular stability of tyrosine hydroxylase. Biochem Biophys Res Commun. 2007; 363(3):817-21. DOI: 10.1016/j.bbrc.2007.09.042. View

Mravec B . Salsolinol, a derivate of dopamine, is a possible modulator of catecholaminergic transmission: a review of recent developments. Physiol Res. 2005; 55(4):353-364. DOI: 10.33549/physiolres.930810. View

Muramatsu S, Fujimoto K, Kato S, Mizukami H, Asari S, Ikeguchi K . A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease. Mol Ther. 2010; 18(9):1731-5. PMC: 2956925. DOI: 10.1038/mt.2010.135. View

Alterio J, Ravassard P, Haavik J, Le Caer J, Biguet N, Waksman G . Human tyrosine hydroxylase isoforms. Inhibition by excess tetrahydropterin and unusual behavior of isoform 3 after camp-dependent protein kinase phosphorylation. J Biol Chem. 1998; 273(17):10196-201. DOI: 10.1074/jbc.273.17.10196. View

Zhu M, Juorio A . Aromatic L-amino acid decarboxylase: biological characterization and functional role. Gen Pharmacol. 1995; 26(4):681-96. DOI: 10.1016/0306-3623(94)00223-a. View

Okita K, Ichisaka T, Yamanaka S . Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448(7151):313-7. DOI: 10.1038/nature05934. View

Halliwell B . Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging. 2001; 18(9):685-716. DOI: 10.2165/00002512-200118090-00004. View

10.

Napolitano A, Cesura A, Da Prada M . The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission. J Neural Transm Suppl. 1995; 45:35-45. View

11.

Su Y, Duan J, Ying Z, Hou Y, Zhang Y, Wang R . Increased vulnerability of parkin knock down PC12 cells to hydrogen peroxide toxicity: the role of salsolinol and NM-salsolinol. Neuroscience. 2013; 233:72-85. DOI: 10.1016/j.neuroscience.2012.12.045. View

12.

Tribl F, Gerlach M, Marcus K, Asan E, Tatschner T, Arzberger T . "Subcellular proteomics" of neuromelanin granules isolated from the human brain. Mol Cell Proteomics. 2005; 4(7):945-57. DOI: 10.1074/mcp.M400117-MCP200. View

13.

Mannisto P, Kaakkola S . Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev. 1999; 51(4):593-628. View

14.

Chaudhry F, Edwards R, Fonnum F . Vesicular neurotransmitter transporters as targets for endogenous and exogenous toxic substances. Annu Rev Pharmacol Toxicol. 2007; 48:277-301. DOI: 10.1146/annurev.pharmtox.46.120604.141146. View

15.

Nagatsu T, Levitt M, UDENFRIEND S . TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS. J Biol Chem. 1964; 239:2910-7. View

16.

Zhang H, Sulzer D . Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors. Basal Ganglia. 2012; 2(1):5-13. PMC: 3375990. DOI: 10.1016/j.baga.2011.11.004. View

17.

Hyman A, Simons K . The new cell biology: Beyond HeLa cells. Nature. 2011; 480(7375):34. DOI: 10.1038/480034a. View

18.

Leal R, Sim A, Goncalves C, Dunkley P . Tyrosine hydroxylase dephosphorylation by protein phosphatase 2A in bovine adrenal chromaffin cells. Neurochem Res. 2002; 27(3):207-13. DOI: 10.1023/a:1014880403970. View

19.

Ichinose H, Ohye T, Fujita K, Pantucek F, Lange K, Riederer P . Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson's disease and schizophrenia. J Neural Transm Park Dis Dement Sect. 1994; 8(1-2):149-58. DOI: 10.1007/BF02250926. View

20.

Crown S, Antoniewicz M . Parallel labeling experiments and metabolic flux analysis: Past, present and future methodologies. Metab Eng. 2012; 16:21-32. PMC: 6474253. DOI: 10.1016/j.ymben.2012.11.010. View